CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy-Reference-Cited by-同舟云学术

CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy

Published:2013 Issue:4 Volume:5 Page:189
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Satoh Daisuke,Yagi Takahito,Nagasaka Takeshi,Shinoura Susumu,Umeda Yuzo,Yoshida Ryuichi,Utsumi Masashi,Tanaka Takehiro,Sadamori Hiroshi,Fujiwara Toshiyoshi

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference35 articles.

1. Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

2. GI Epidemiology: nonalcoholic fatty liver disease

3. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

4. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway;Heliyon;2024-07

2. Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?;JGH Open;2024-06

3. Risk factors of developing nonalcoholic fatty liver disease after pancreatic resection: a systematic review and meta-analysis;Journal of Gastrointestinal Surgery;2024-06

4. Incidence and clinical characteristics of hepatic steatosis following pancreatectomy;The Showa University Journal of Medical Sciences;2024

5. Development of de novo nonalcoholic fatty liver disease following pancreatectomy;Medicine;2023-01-27